# CareCloud, Inc.: financial statements, quarterly

CCLD · Nasdaq · CIK 1582982 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ccld.md) · [Financials](/companies/ccld/financials.md) · [Filings](/companies/ccld/filings.md) · [Insiders](/companies/ccld/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ccld/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [29.3](/filings/0001493152-24-044794.md) | [28.4 d](/filings/0001641172-25-002589.md) | [26.0](/filings/0001641172-25-008857.md) | [28.1](/filings/0001641172-25-022265.md) | [28.5](/filings/0001493152-25-021079.md) | [28.2 d](/filings/0001493152-26-009872.md) | [27.6](/filings/0001493152-26-021730.md) | [27.4](/filings/0001493152-26-036363.md) | [31.1](/filings/0001493152-25-021079.md) | [34.4 d](/filings/0001493152-26-009872.md) | [31.3](/filings/0001493152-26-021730.md) | [31.9](/filings/0001493152-26-036363.md) |
| Research and development | $m | [1.3](/filings/0001493152-24-044794.md) | [1.2 d](/filings/0001641172-25-002589.md) | [0.9](/filings/0001641172-25-008857.md) | [1.1](/filings/0001641172-25-022265.md) | [0.8](/filings/0001493152-25-021079.md) | [1.0 d](/filings/0001493152-26-009872.md) | [1.2](/filings/0001493152-26-021730.md) | [1.0](/filings/0001493152-26-036363.md) | [1.6](/filings/0001493152-25-021079.md) | [2.5 d](/filings/0001493152-26-009872.md) | [2.4](/filings/0001493152-26-021730.md) | [2.2](/filings/0001493152-26-036363.md) |
| Operating income | $m | [(2.0)](/filings/0001493152-24-044794.md) | [(43.6) d](/filings/0001641172-25-002589.md) | [0.1](/filings/0001641172-25-008857.md) | [2.3](/filings/0001641172-25-022265.md) | [3.3](/filings/0001493152-25-021079.md) | [3.5 d](/filings/0001493152-26-009872.md) | [2.0](/filings/0001493152-26-021730.md) | [3.0](/filings/0001493152-26-036363.md) | [3.2](/filings/0001493152-25-021079.md) | [3.1 d](/filings/0001493152-26-009872.md) | [1.0](/filings/0001493152-26-021730.md) | [1.9](/filings/0001493152-26-036363.md) |
| Income tax | $m | [0.1](/filings/0001493152-24-044794.md) | [(0.6) d](/filings/0001641172-25-002589.md) | [0.0](/filings/0001641172-25-008857.md) | [0.0](/filings/0001641172-25-022265.md) | [0.0](/filings/0001493152-25-021079.md) | [0.0 d](/filings/0001493152-26-009872.md) | [0.0](/filings/0001493152-26-021730.md) | [0.0](/filings/0001493152-26-036363.md) | [0.0](/filings/0001493152-25-021079.md) | [0.1 d](/filings/0001493152-26-009872.md) | [0.1](/filings/0001493152-26-021730.md) | [0.1](/filings/0001493152-26-036363.md) |
| Net income | $m | [(2.7)](/filings/0001493152-24-044794.md) | [(43.7) d](/filings/0001641172-25-002589.md) | [(0.2)](/filings/0001493152-25-021079.md) | [1.7](/filings/0001493152-25-021079.md) | [3.1](/filings/0001493152-25-021079.md) | [3.3 d](/filings/0001493152-26-009872.md) | [1.9](/filings/0001493152-26-036363.md) | [2.9](/filings/0001493152-26-036363.md) | [3.1](/filings/0001493152-25-021079.md) | [2.9 d](/filings/0001493152-26-009872.md) | [0.9](/filings/0001493152-26-036363.md) | [1.1](/filings/0001493152-26-036363.md) |
| Diluted EPS | $ per share | [(0.42)](/filings/0001493152-24-044794.md) | not reported | [(0.10)](/filings/0001641172-25-008857.md) | [(0.14)](/filings/0001641172-25-022265.md) | [(0.04)](/filings/0001493152-25-021079.md) | not reported | [(0.04)](/filings/0001493152-26-021730.md) | [0.04](/filings/0001493152-26-036363.md) | [0.04](/filings/0001493152-25-021079.md) | not reported | [(0.01)](/filings/0001493152-26-021730.md) | [0.00](/filings/0001493152-26-036363.md) |
| Basic EPS | $ per share | [(0.42)](/filings/0001493152-24-044794.md) | not reported | [(0.10)](/filings/0001641172-25-008857.md) | [(0.14)](/filings/0001641172-25-022265.md) | [(0.04)](/filings/0001493152-25-021079.md) | not reported | [(0.04)](/filings/0001493152-26-021730.md) | [0.04](/filings/0001493152-26-036363.md) | [0.04](/filings/0001493152-25-021079.md) | not reported | [(0.01)](/filings/0001493152-26-021730.md) | [0.00](/filings/0001493152-26-036363.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [3.3](/filings/0001641172-25-002589.md) | [4.1](/filings/0001493152-24-019276.md) | [2.6](/filings/0001493152-24-031637.md) | [2.8](/filings/0001493152-24-044794.md) | [5.1](/filings/0001493152-26-009872.md) | [6.8](/filings/0001641172-25-008857.md) | [10.4](/filings/0001641172-25-022265.md) | [4.3](/filings/0001493152-25-021079.md) | [3.1](/filings/0001493152-26-036363.md) | [3.4](/filings/0001493152-26-021730.md) | [13.4](/filings/0001493152-26-036363.md) |
| Current assets | $m | [27.5](/filings/0001493152-23-039155.md) | [23.2](/filings/0001641172-25-002589.md) | [24.3](/filings/0001493152-24-019276.md) | [23.9](/filings/0001493152-24-031637.md) | [22.7](/filings/0001493152-24-044794.md) | [24.8](/filings/0001493152-26-009872.md) | [28.6](/filings/0001641172-25-008857.md) | [31.1](/filings/0001641172-25-022265.md) | [29.3](/filings/0001493152-25-021079.md) | [25.7](/filings/0001493152-26-036363.md) | [26.1](/filings/0001493152-26-021730.md) | [34.2](/filings/0001493152-26-036363.md) |
| Total assets | $m | [126](/filings/0001493152-23-039155.md) | [77.8](/filings/0001641172-25-002589.md) | [76.9](/filings/0001493152-24-019276.md) | [74.0](/filings/0001493152-24-031637.md) | [70.7](/filings/0001493152-24-044794.md) | [71.6](/filings/0001493152-26-009872.md) | [73.6](/filings/0001641172-25-008857.md) | [75.2](/filings/0001641172-25-022265.md) | [90.6](/filings/0001493152-25-021079.md) | [87.6](/filings/0001493152-26-036363.md) | [86.7](/filings/0001493152-26-021730.md) | [93.8](/filings/0001493152-26-036363.md) |
| Current liabilities | $m | [21.9](/filings/0001493152-23-039155.md) | [23.3](/filings/0001641172-25-002589.md) | [23.8](/filings/0001493152-24-019276.md) | [23.2](/filings/0001493152-24-031637.md) | [21.9](/filings/0001493152-24-044794.md) | [19.6](/filings/0001493152-26-009872.md) | [16.9](/filings/0001641172-25-008857.md) | [16.2](/filings/0001641172-25-022265.md) | [23.2](/filings/0001493152-25-021079.md) | [24.4](/filings/0001493152-26-036363.md) | [23.5](/filings/0001493152-26-021730.md) | [33.5](/filings/0001493152-26-036363.md) |
| Total liabilities | $m | [37.8](/filings/0001493152-23-039155.md) | [36.1](/filings/0001641172-25-002589.md) | [35.5](/filings/0001493152-24-019276.md) | [30.8](/filings/0001493152-24-031637.md) | [24.2](/filings/0001493152-24-044794.md) | [21.8](/filings/0001493152-26-009872.md) | [19.4](/filings/0001641172-25-008857.md) | [19.2](/filings/0001641172-25-022265.md) | [32.8](/filings/0001493152-25-021079.md) | [28.1](/filings/0001493152-26-036363.md) | [28.4](/filings/0001493152-26-021730.md) | [76.4](/filings/0001493152-26-036363.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [88.2](/filings/0001493152-24-044794.md) | [41.7](/filings/0001493152-26-009872.md) | [41.4](/filings/0001493152-25-021079.md) | [43.2](/filings/0001493152-25-021079.md) | [46.5](/filings/0001493152-25-021079.md) | [49.8](/filings/0001493152-26-036363.md) | [54.2](/filings/0001493152-26-036363.md) | [56.1](/filings/0001493152-26-036363.md) | [57.8](/filings/0001493152-25-021079.md) | [59.5](/filings/0001493152-26-036363.md) | [58.3](/filings/0001493152-26-036363.md) | [17.4](/filings/0001493152-26-036363.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [4,313 d](/filings/0001493152-24-044794.md) | [3,740 d](/filings/0001641172-25-002589.md) | [4,066](/filings/0001641172-25-008857.md) | [4,279 d](/filings/0001641172-25-022265.md) | [7,068 d](/filings/0001493152-25-021079.md) | [5,229 d](/filings/0001493152-26-009872.md) | [5,113](/filings/0001493152-26-021730.md) | [7,408 d](/filings/0001493152-26-036363.md) | [7,365 d](/filings/0001493152-25-021079.md) | [8,675 d](/filings/0001493152-26-009872.md) | [3,611](/filings/0001493152-26-021730.md) | [7,073 d](/filings/0001493152-26-036363.md) |
| Capital expenditure | $k | [1,066 d](/filings/0001493152-24-044794.md) | [376 d](/filings/0001641172-25-002589.md) | [298](/filings/0001641172-25-008857.md) | [127 d](/filings/0001641172-25-022265.md) | [334 d](/filings/0001493152-25-021079.md) | [938 d](/filings/0001493152-26-009872.md) | [624](/filings/0001493152-26-021730.md) | [1,162 d](/filings/0001493152-26-036363.md) | [869 d](/filings/0001493152-25-021079.md) | [2,123 d](/filings/0001493152-26-009872.md) | [412](/filings/0001493152-26-021730.md) | [525 d](/filings/0001493152-26-036363.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.1](/filings/0001493152-23-039155.md) | [15.4](/filings/0001493152-24-019276.md) | [15.6](/filings/0001493152-24-031637.md) | [15.8](/filings/0001493152-24-044794.md) | [16.0](/filings/0001641172-25-008857.md) | [16.1](/filings/0001641172-25-022265.md) | [16.2](/filings/0001493152-25-021079.md) | [23.8](/filings/0001493152-26-021730.md) | [42.3](/filings/0001493152-26-036363.md) | [42.4](/filings/0001493152-25-021079.md) | [42.5](/filings/0001493152-26-021730.md) | [42.5](/filings/0001493152-26-036363.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,493,859 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001493152-26-036363.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.